Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Details

Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers; Guidance for Industry; Draft Guidance

FDA-2024-D-2581-0002Other
Document

Details

The document's own metadata, straight from the source system.

Title
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers; Guidance for Industry; Draft Guidance
Posted
Jul 23, 2024
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗